Biotechnology Stocks I Performance Guide: Sarepta Therapeutics, Inc. (SRPT)
SRPT has no dividends
Table and Chart of SRPT Performance
See what a $1,000 investment in SRPT is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| SRPT Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $20.37 |
| End Date | Dec-01-2023 |
| End Price | $84.44 |
| # Prices | 121 |
| Min Date | Jan-29-2016 |
| Min Price | $11.88 |
| Max Date | Dec-31-2020 |
| Max Price | $170.49 |
| Total Return | 314.53% |
| Annualized Return | 15.15% |
| Current Value of $1,000 Purchase | $4,145 |
| Number Returns | 7,260 |
| Average Return | 178.61% |
| Number Profitable Returns | 5,506 |
| Percent Profitable Returns | 75.84% |
| Number Unprofitable Returns | 1,754 |
| Percent Unprofitable Returns | 24.16% |
| Profitable to Unprofitable Returns Ratio | 3.14 |
| SRPT Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $7,899,084,000 | Price to Sales | 7.15 |
| Earnings per Share | $-7.8000 |
| PE Ratio | None |
| PE to Growth Ratio | 159.25 |
| Price to Book | 10.33 |
| PRICE DATA | |
| 52 Week High | $159.89 |
| 52 Week Low | $55.25 |
| Analyst Target Price | $140.28 |
| 50-Day Moving Average | $100.44 |
| 200-Day Moving Average | $118.16 |
| FINANCIAL DATA | |
| Revenue per Share | $12.5 |
| Revenue | $1,104,982,000 |
| Profit Margin | -62.5% |
| Return on Equity | -1.156% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
SRPT Compare Returns with S&P 500
SRPT Trendline Chart